Infliximab for 6 months added on combination therapy in early rheumatoid arthritis. 2-year results from an investigator-initiated, randomized, double-blind, placebo-controlled study (The NEO-RACo Study)

Marjatta Leirisalo-Repo, Hannu Kautiainen, Leena Laasonen, Markku Korpela, Markku Kauppi, Oili Kaipiainen-Seppänen, Riitta Luosujärvi, Reijo Luukkainen, Anna Karjalainen, Harri Blåfield, Toini Uutela, Kirsti Ilva, Heikki Julkunen, Leena Paimela, Kari Puolakka, Eeva Moilanen, Pekka Hannonen, Timo Möttönen, Riina Nieminen, Katriina Vuolteenaho

    Research output: Contribution to journalArticleScientificpeer-review

    62 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)851-857
    JournalANNALS OF THE RHEUMATIC DISEASES
    Volume72
    Issue number6
    DOIs
    Publication statusPublished - 2013
    Publication typeA1 Journal article-refereed

    Publication forum classification

    • Publication forum level 3

    Cite this